| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Tiziana Life Sciences PLC (LSE: TILS)
TILS Technical Analysis
1.5
| As on 20th Oct 2021 TILS STOCK Price closed @ 117.00 and we RECOMMEND Buy for LONG-TERM with Stoploss of 99.90 & Sell for SHORT-TERM with Stoploss of 120.69 we also expect STOCK to react on Following IMPORTANT LEVELS. |
TILSSTOCK Price
| Open | 111.00 | Change | Price | % |
| High | 118.00 | 1 Day | 9.00 | 8.33 |
| Low | 90.00 | 1 Week | 62.90 | 116.27 |
| Close | 117.00 | 1 Month | 51.00 | 77.27 |
| Volume | 148564 | 1 Year | -18.00 | -13.33 |
| 52 Week High 204.00 | 52 Week Low 48.50 | ||||
LSE UK Most Active Stocks
| DKE | 0.15 | 0.00% |
| NNN | 0.09 | 50.00% |
| SYME | 0.10 | -9.09% |
| DMTR | 0.03 | 0.00% |
| PREM | 0.53 | 3.92% |
| MCLS | 1.68 | 46.09% |
| YGEN | 0.49 | 0.00% |
| CLON | 0.11 | 0.00% |
| VOD | 71.04 | 0.57% |
| BOIL | 0.10 | 0.00% |
LSE UK Top Gainers Stocks
LSE UK Top Losers Stocks
| TILS Daily Charts |
TILS Intraday Charts |
Whats New @ Bazaartrend |
TILS Free Analysis |
|
|
TILS Important Levels Intraday
| RESISTANCE | 170.96 |
| RESISTANCE | 153.65 |
| RESISTANCE | 142.96 |
| RESISTANCE | 132.26 |
| SUPPORT | 101.74 |
| SUPPORT | 91.04 |
| SUPPORT | 80.35 |
| SUPPORT | 63.04 |
TILS Forecast May 2024
| 4th UP Forecast | 352.09 |
| 3rd UP Forecast | 276.7 |
| 2nd UP Forecast | 230.09 |
| 1st UP Forecast | 183.49 |
| 1st DOWN Forecast | 50.51 |
| 2nd DOWN Forecast | 3.91 |
| 3rd DOWN Forecast | -42.7 |
| 4th DOWN Forecast | -118.09 |
TILS Weekly Forecast
| 4th UP Forecast | 205.64 |
| 3rd UP Forecast | 177.21 |
| 2nd UP Forecast | 159.64 |
| 1st UP Forecast | 142.07 |
| 1st DOWN Forecast | 91.93 |
| 2nd DOWN Forecast | 74.36 |
| 3rd DOWN Forecast | 56.79 |
| 4th DOWN Forecast | 28.36 |
TILS Forecast2024
| 4th UP Forecast | 456.15 |
| 3rd UP Forecast | 347.38 |
| 2nd UP Forecast | 280.15 |
| 1st UP Forecast | 212.92 |
| 1st DOWN Forecast | 21.08 |
| 2nd DOWN Forecast | -46.15 |
| 3rd DOWN Forecast | -113.38 |
| 4th DOWN Forecast | -222.15 |
Tiziana Life Sciences PLC ( LSE UK Symbol : TILS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
TILS Business Profile
Tiziana Life Sciences plc, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology, inflammation, and infectious diseases. Its lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. The company is also developing Milciclib (TZLS-201), a small molecule inhibitor of various cyclin-dependent kinases, tropomycin receptor kinases, and Src family kinases controlling cell growth and malignant progression of cancer; and anti-Interleukin 6 receptor (IL6R) mAb (TZLS-501), a fully human monoclonal antibody for the treatment of IL6-induced inflammation, primarily to treat COVID-19 patients. It has a collaboration agreement with FHI Clinical to conduct a Phase 2 clinical trials for treating hospitalized severe COVID-19 patients with intranasal foralumab. The company was incorporated in 1998 and is based in London, the United Kingdom. Address: 107 Cheapside, London, United Kingdom, EC2V 6DN
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service